XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study von Torgerson, Jarl S., Hauptman, Jonathan, Boldrin, Mark N., Sjöström, Lars

Volltext

Xenical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in o... von TORGERSON, Jarl S, HAUPTMAN, Jonathan, BOLDRIN, Mark N, SJÖSTRÖM, Lars

Volltext

Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia von Lucas, Charles P, Boldrin, Mark N, Reaven, Gerald M

Volltext

P-591: Effect of orlistat in patients with hypertension and either high or normal fasting insulin levels von Reaven, Gerald M., Segal, Karen R., Hauptman, Jonathan, Boldrin, Mark N., Lucas, Charles P.

Volltext

Effect of orlistat in patients with hypertension and either high or normal fasting insulin levels von Reaven, Gerald M, Segal, Karen R, Hauptman, Jonathan, Boldrin, Mark N, Lucas, Charles P

Volltext

Orlistat in the long-term treatment of obesity in primary care settings von Hauptman, J, Lucas, C, Boldrin, M N, Collins, H, Segal, K R

Volltext